🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis

RecruitingNAAges 18 Years - 65 YearsAllAnkara City Hospital Bilkent
NCT07864948 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate and compare the short- and mid-term effects of Extracorporeal Shock Wave Therapy (ESWT) alone versus a combination of ESWT and Kinesio Taping (KT) on pain, foot functionality, and plantar fascia thickness in patients with plantar fasciitis. A total of 48 patients with chronic plantar fasciitis will be included in this prospective, randomized controlled trial and randomly allocated into two groups: the ESWT group and the ESWT + Kinesio Taping group. Primary outcome measures include pain severity assessed via the Visual Analog Scale (VAS) for morning and general pain, foot functionality evaluated using the Foot Function Index (FFI), and plantar fascia thickness measured via ultrasonography. Evaluations will be conducted at baseline, immediately post-treatment, and at the 3-month follow-up.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Age between 18 and 65 years Chronic heel pain for at least 3 months Localized pain and tenderness on palpation at the medial aspect of the calcaneal tuberosity with the ankle in full dorsiflexion Pain intensity of 50 mm or greater on the Visual Analog Scale (VAS) during the first step in the morning Ultrasonographic findings typical of plantar fasciitis (proximal plantar fascia thickness greater than 4 mm with alterations in the fibrillar pattern) Willingness to participate in the study and provide written informed consent Exclusion Criteria: Presence of any skin lesions or integrity disruption in the heel region History of inflammatory or rheumatic arthritis History of fracture, trauma, or surgery in the heel region Presence of systemic infection or malignancy Presence of a cardiac pacemaker Local injection into the heel region within the last 6 months, or use of topical or oral non-steroidal anti-inflammatory drugs (NSAIDs) within the last 2 weeks Unwillingness to participate in the study
💊

What it tests

  • Kinesio Taping
  • Extracorporeal Shock Wave Therapy (ESWT)
📍

Where

1 site
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy